Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
← catalyst calendarSponsored by Monopar Therapeutics (industry) · MNPR — their whole pipeline →.
Phase
Phase 1
Status
Recruiting
Study type
Interventional
Design
Na · None · Diagnostic
Enrollment
12estimated
Sites
1
Country
Australia
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-05-30 | actual | When the study began enrolling |
| Primary completion | Apr 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Apr 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2024-03-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-05-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Solid Tumor, Adult
- Bladder Cancer
- Urothelial Carcinoma
- Triple-negative Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Gastric Cancer
- Ovarian Cancer
- Pancreatic Cancer
Interventions
- Drug: MNPR-101-DFO*-89Zr
- Diagnostic test: PET/CT Diagnostic Imaging
Primary outcomes
what the primary-completion date above is the date OFTo assess dosimetry and biodistribution of MNPR-101-DFO*-89Zr
measured Post infusion at 2 h on Day 1, once on Days 3-5, and once on Days 7-10.
To assess tumor Standard Uptake Value (SUV) of MNPR-101-DFO*-89Zr
measured Post infusion at 2 h on Day 1, once on Days 3-5, and once on Days 7-10.
To assess safety of MNPR-101-DFO*-89Zr as assessed by CTCAE 5.0
measured Screening through Day 30 Safety Visit.
Permalink · MNPR's whole pipeline · Catalyst calendar · Every registered study · What changed